KSQ Therapeutics' Series B Round

KSQ Therapeutics raised a round of funding on October 02, 2017.

KSQ Therapeutics aims to advance drugs via its proprietary CRISPRomics, which rules out inferior options from the outset, thereby focusing R&D investment on candidates with the greatest potential impa…

Articles about KSQ Therapeutics' Series B Round: